STOCK TITAN

DGX (NYSE: DGX) plans Rule 144 sale of 5,662 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of DGX common stock has filed a notice of intent to sell 5,662 shares under Rule 144. The planned sale, through Fidelity Brokerage Services LLC on the NYSE, has an stated aggregate market value of $1,155,048.00.

The shares are part of DGX common stock, with 111,242,362 shares outstanding at the time referenced. The seller acquired these 5,662 shares on 02/10/2026 by exercising a stock option originally granted on 02/17/2021, and paid the purchase price in cash.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many DGX shares are planned for sale under this Rule 144 notice?

The notice covers a planned sale of 5,662 DGX common shares. These shares were acquired through an option exercise and will be sold through a broker on a national exchange, subject to Rule 144 conditions.

What is the aggregate market value of the DGX shares to be sold?

The planned sale has an aggregate market value of $1,155,048.00. This figure reflects the total market value of the 5,662 DGX common shares covered by the notice at the time the information was provided.

When were the DGX shares being sold under Rule 144 acquired?

The 5,662 DGX common shares were acquired on 02/10/2026. They came from exercising a stock option that was originally granted on 02/17/2021, with the purchase price paid in cash at the time of exercise.

What was the nature of the transaction used to acquire the DGX shares?

The shares were obtained via an option granted on 02/17/2021, which was exercised on 02/10/2026. The holder paid cash for 5,662 DGX common shares as part of this option exercise transaction.

Which broker and exchange are involved in this DGX Rule 144 sale?

The planned Rule 144 sale will use Fidelity Brokerage Services LLC as broker. The 5,662 DGX common shares are expected to be sold on the New York Stock Exchange (NYSE), according to the information provided.

How many DGX common shares were outstanding when this sale was planned?

The filing lists 111,242,362 DGX common shares outstanding. This figure provides context for the relative size of the planned 5,662-share sale described under Rule 144 in the notice.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

21.22B
110.75M
0.4%
99.16%
3.8%
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS